SCHEMBL14480980

SCHEMBL14480980

[2H]C([2H])([2H])N(C(=O)c1cc(Oc2ccc(N(C(N)=O)c3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1)C([2H])([2H])[2H]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 12/20 0.59
KDR P35968 6/20 0.49
BRAF P15056 5/20 0.49
RET P07949 3/20 0.49
EPHX2 P34913 3/20 0.49
RIPK2 O43353 2/20 0.49
ABCB11 O95342 2/20 0.49
ABL1 P00519 2/20 0.49
HTR1A P08908 2/20 0.49
PDGFRB P09619 2/20 0.49
ADORA3 P0DMS8 2/20 0.49
KIT P10721 2/20 0.49
FGFR1 P11362 2/20 0.49
PDGFRA P16234 2/20 0.49
FLT1 P17948 2/20 0.49
MAOA P21397 2/20 0.49
EPHA1 P21709 2/20 0.49
TBXA2R P21731 2/20 0.49
EPHA2 P29317 2/20 0.49
TTK P33981 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6012882 0.88 RAF1 (0.66) RAF1KDRBRAFRETEPHX2
SCHEMBL14481187 0.87 RAF1 (0.59) RAF1KDRBRAFRETEPHX2
SCHEMBL694648 0.85 RAF1 (0.67) RAF1KDRBRAFRETEPHX2
Hydrochloric Acid SCHEMBL1702120 0.85 RAF1 (0.66) RAF1KDRBRAFRETEPHX2
Hydrochloric Acid SCHEMBL1702492 0.84 RAF1 (0.65) RAF1KDRBRAFRETEPHX2
SCHEMBL16143280 0.83 RAF1 (0.68) RAF1KDRBRAFRETEPHX2
Sulfuric Acid SCHEMBL2043327 0.82 RAF1 (0.63) RAF1KDRBRAFRETEPHX2
SCHEMBL1702479 0.82 RAF1 (0.63) RAF1KDRBRAFRETEPHX2
SCHEMBL26239025 0.81 RAF1 (0.70) RAF1KDRBRAFRETEPHX2
SCHEMBL14480612 0.81 RAF1 (0.88) RAF1KDRBRAFRETEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130012548-A1 DEUTERIUM-SUBSTITUTED OMEGA-DIPHENYLUREA AND DERIVATIVES THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS SUZHOU ZELGEN BIOPHARMACEUTICAL CO., LTD. (CN) 2013-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012548-A1 DEUTERIUM-SUBSTITUTED OMEGA-DIPHENYLUREA AND DERIVATIVES THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS PPARD, HDHD5, SCD RAF1 2908/4885KDR 1916/4885BRAF 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.